Handelsbanken Fonder AB Has $401,000 Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Handelsbanken Fonder AB grew its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 148.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 29,800 shares of the company's stock after purchasing an additional 17,800 shares during the period. Handelsbanken Fonder AB's holdings in Oscar Health were worth $401,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Creative Planning grew its holdings in shares of Oscar Health by 73.8% during the 3rd quarter. Creative Planning now owns 31,296 shares of the company's stock valued at $664,000 after purchasing an additional 13,286 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after buying an additional 844 shares in the last quarter. US Bancorp DE grew its stake in shares of Oscar Health by 115.9% during the third quarter. US Bancorp DE now owns 24,784 shares of the company's stock worth $526,000 after buying an additional 13,305 shares during the last quarter. Janney Montgomery Scott LLC acquired a new position in shares of Oscar Health during the third quarter worth $988,000. Finally, Harbor Capital Advisors Inc. bought a new position in shares of Oscar Health in the 3rd quarter valued at $1,943,000. Institutional investors and hedge funds own 75.70% of the company's stock.

Oscar Health Trading Up 3.1 %

Shares of NYSE OSCR traded up $0.46 during trading on Monday, reaching $15.07. The company had a trading volume of 4,844,938 shares, compared to its average volume of 4,578,920. The stock has a market cap of $3.78 billion, a P/E ratio of -753.12 and a beta of 1.73. The company's fifty day moving average price is $14.97 and its 200-day moving average price is $16.57. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $12.43 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on OSCR. Jefferies Financial Group assumed coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Bank of America cut Oscar Health from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Oscar Health currently has an average rating of "Hold" and a consensus target price of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.